| | | | | | | |
 | JOHNSON & JOHNSON | -0.09% | 3.17% | 4.90% | 6.15% | 29.25% | 472 231 |
 | ROCHE HOLDING AG | -0.99% | 3.66% | -13.03% | 5.29% | 21.24% | 282 336 |
| ELI LILLY AND COMPANY | 2.10% | 9.50% | 13.48% | 55.96% | 168.40% | 282 164 |
| ABBVIE INC. | -0.91% | -0.76% | 11.20% | 31.27% | 88.07% | 266 074 |
| NOVO NORDISK A/S | 1.28% | 2.45% | -4.82% | 32.69% | 119.39% | 242 093 |
| MERCK & CO., INC. | -1.54% | 0.24% | 20.45% | 19.53% | 13.72% | 233 434 |
 | ASTRAZENECA PLC | -0.17% | 2.89% | 21.32% | 29.97% | 77.30% | 205 677 |
| NOVARTIS AG | 0.01% | 2.94% | 4.33% | 2.36% | 4.27% | 198 211 |
| BRISTOL-MYERS SQUIBB COMPANY | 0.45% | 2.15% | 24.44% | 17.33% | 65.76% | 165 194 |
 | SANOFI | -1.29% | 3.54% | 15.44% | 17.72% | 35.32% | 138 769 |
| AMGEN INC. | 0.02% | 3.38% | 12.48% | 6.08% | 47.74% | 135 179 |
| GLAXOSMITHKLINE PLC | -0.66% | 1.28% | 8.44% | 30.01% | 12.63% | 111 724 |
 | BAYER AG | -0.50% | 3.94% | 39.51% | 25.61% | 19.94% | 69 450 |
 | DAIICHI SANKYO CO., LTD. | -1.79% | 5.65% | 16.24% | 35.38% | 81.49% | 52 109 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | -0.48% | 2.20% | 19.35% | -1.73% | -5.02% | 45 598 |
| | | | | | | |
| | Gemiddelde | -0.30% | 3.08% | 12.92% | 20.91% | 51.97% | |
| | Gewogen gemiddelde per kap. | -0.13% | 3.09% | 9.50% | 20.91% | 58.15% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
Rapport
